This site is intended for healthcare professionals
  • Home
  • /
  • News
  • /
  • FDA provide complete response letter for Ayvakit i...
News

FDA provide complete response letter for Ayvakit in fourth-line gastrointestinal stromal tumor.- Blueprint Medicines

Read time: 1 mins
Last updated:18th May 2020
Published:16th May 2020
Condition: GIST
Type: drug
Register now for full access to medthority.com